Mesothelioma Trial, Recruiting NCT06538376 Sponsor: Brigham and Women's Hospital Condition: Mesothelioma
Back to Mesothelioma

Mesothelioma Trial, Recruiting

NCT06538376
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be an adult aged 18 or older (whether or not you are on a breathing machine)
  • You likely have a condition affecting how your diaphragm moves, how your lungs are working, fluid in your lungs, or difficulty swallowing safely
  • You, or someone legally authorised to make decisions on your behalf, must be willing and able to sign a consent form

Who may not be able to join:

  • Women who are known to be pregnant, people who are in prison, or people living in certain institutional settings
  • People for whom receiving additional radiation would be medically unsafe
  • People whose medical care team has not agreed to allow them or their representative to be approached about the study
  • Women who could potentially become pregnant (i.e., who have not yet gone through menopause or had a surgical procedure to prevent pregnancy) will need to take a pregnancy test to confirm they are not pregnant before joining — women who are post-menopausal or have had a sterilisation procedure will not need this test

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gyorgy Frendl, MD PhD, Brigham and Women's Hospital

Phone: 617-732-5910

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
12 December 2023
Est. completion
1 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

I. Extended clinical trial to study the degree of precision of the Portable DDR technology in assessing the cardiopulmonary functions of diaphragm and lung motion.; II. Extended clinical trial to study the degree of precision of the Portable DDR technology in assessing the cardiopulmonary functions of pulmonary blood flow.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov